liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Pharmacogenomics in the evaluation of efficacy and adverse events during clinical development of vaccines
School of Pharmacy, University of Connecticut, Storrs, CT, USA.
Linköping University, Department of Clinical and Experimental Medicine, Pediatrics. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Center of Paediatrics and Gynaecology and Obstetrics, Department of Paediatrics in Linköping.
2008 (English)In: Pharmacogenomics in Drug Discovery and Development: From Bench to Bedside / [ed] Qing Yan, Humana Press, 2008, Vol. 448, 469-479 p.Chapter in book (Other academic)
Abstract [en]

The understanding of vaccine-induced immune responses in adults and infants is limited. Current vaccination schedules for infants are frequently debated. Especially, the relationship among the timing, the frequency of the dosing, and the generation of an immunological memory are debated. Vaccine antigen-induced cytokine responses to vaccinations given in infancy are of particular interest because little is known about cellular responses in this age, and the information available is based on antibody responses. Pharmacogenomics is ideally suited to study cellular responses related to immune response, in addition, toxicity, inflammation, apoptosis, stress, and oncogenesis can be monitored, since the expression of thousands of genes can be measured in a single experiment. © 2008 Humana Press, a part of Springer Science + Business Media, LLC.

Place, publisher, year, edition, pages
Humana Press, 2008. Vol. 448, 469-479 p.
Series
Methods in Molecular Biology, ISSN 1064-3745 ; 448
Keyword [en]
Adverse reactions, Clinical study, Efficacy, Microarray, PBMCs, Pharmacogenomics, Vaccine
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:liu:diva-45766DOI: 10.1007/978-1-59745-205-2_17PubMedID: 18370243ISBN: 978-1-58829-887-4 (print)ISBN: 978-1-59745-205-2 (print)OAI: oai:DiVA.org:liu-45766DiVA: diva2:266662
Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2015-11-18Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

Nilsson, Lennart

Search in DiVA

By author/editor
Nilsson, Lennart
By organisation
PediatricsFaculty of Health SciencesDepartment of Paediatrics in Linköping
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
isbn
urn-nbn

Altmetric score

doi
pubmed
isbn
urn-nbn
Total: 44 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf